Corcept Director Holds Million Shares Through Rebound
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
Planning your retirement portfolio at 40? Discover essential assets to include for a balanced and secure financial future.
20,742 articlesImagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
A trio of durable cash-flow stocks offer steady dividends and room to grow, giving investors a balanced path through ...
Berkshire Hathaway disclosed a $351.7 million investment in The New York Times, marking a surprising return to tradit...
DraftKings posted strong top-line growth yet issued cautious guidance, sending its stock lower. This analysis breaks ...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
Dive into a practical guide on Revolution Medicines earnings. Learn to parse transcripts, spot the signals that matte...
A trio of megacaps—NVIDIA, Alphabet, and Amazon—has caught the eye of stocks wall street analysts as the era of AI fu...
A new study shows a widening gap between the skills-based hiring mantra and its execution, as more than half of emplo...
As geopolitical risk stays elevated, investors are reevaluating defense allocations. Lessons from WWII’s most feared ...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
Jim Cramer signals a clear pecking order in payments, naming Klarna as the one to avoid while highlighting Affirm and...
The AI hype is undeniable, but investors want answers: is this a bubble about burst just or the start of a longer asc...